METROMIDOL Drug Patent Profile
✉ Email this page to a colleague
When do Metromidol patents expire, and what generic alternatives are available?
Metromidol is a drug marketed by Labs Af and is included in one NDA.
The generic ingredient in METROMIDOL is metronidazole. There are eighteen drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metromidol
A generic version of METROMIDOL was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for METROMIDOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 3,923 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METROMIDOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METROMIDOL
US Patents and Regulatory Information for METROMIDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Labs Af | METROMIDOL | metronidazole | TABLET;ORAL | 074523-001 | Oct 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Labs Af | METROMIDOL | metronidazole | TABLET;ORAL | 074523-002 | Oct 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |